Anzeige
Mehr »
Sonntag, 18.01.2026 - Börsentäglich über 12.000 News
Silber bei 90. Gold bei 4.600. Kupfer bei 6. - Top-Aktie im Fokus
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A402W5 | ISIN: US3179701012 | Ticker-Symbol:
NASDAQ
16.01.26 | 22:00
1,030 US-Dollar
-0,96 % -0,010
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
FIREFLY NEUROSCIENCE INC Chart 1 Jahr
5-Tage-Chart
FIREFLY NEUROSCIENCE INC 5-Tage-Chart

Aktuelle News zur FIREFLY NEUROSCIENCE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
19.12.25FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report2
18.11.25FIREFLY NEUROSCIENCE, INC. - S-8, Securities to be offered to employees in employee benefit plans1
12.11.25Firefly Neuroscience, Inc. GAAP EPS of $0.205
12.11.25Firefly Neuroscience, Inc.: Firefly Neuroscience Reports Third Quarter 2025 Financial Results146- Quarterly performance characterized by higher revenues, reduced cost structure and improved bottom line - - Successful business integration drives 10.9% sequential quarter-over-quarter EEG/ERP...
► Artikel lesen
12.11.25FIREFLY NEUROSCIENCE, INC. - 10-Q, Quarterly Report-
31.10.25FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report1
05.09.25FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report4
FIREFLY NEUROSCIENCE Aktie jetzt für 0€ handeln
05.09.25Firefly Neuroscience, Inc.: Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America1
26.08.25Firefly Neuroscience, Inc.: Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen 'CLEAR' Platform10
13.08.25FIREFLY NEUROSCIENCE, INC. - 10-Q, Quarterly Report2
14.07.25Firefly Neuroscience, Inc.: Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA Platform in Groundbreaking Precision Neuroscience Research261- Institute of Human Genetics at Heidelberg University Hospital ongoing EEG biomarker study on 15q13.3 CNVs - - Collaboration aims to uncover novel insights into the brain's functional architecture...
► Artikel lesen
05.05.25Firefly Neuroscience, Inc.: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.408Builds upon Firefly's recent acceptance into the NVIDIA Connect program Marks next major step toward building a proprietary foundation model of the human brain KENMORE, N.Y., May 05, 2025 (GLOBE NEWSWIRE)...
► Artikel lesen
06.03.25Hemostemix Inc.: Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01486Calgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell company that has safely treated...
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1